• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600

Print

AXA Framlington Biotech Fund - Z Acc

Specialist
Price: 446.80p|Change: 6.60 (1.50%)

Pricing frequency 

Daily

Dealing cut off time 

11:00

Type 

Unit Trust

Yield 

–

NAV 

446.80p

Income frequency 

Semi-annually

Ongoing charge 

0.82%

Latest actual NAV date 

12-05-2025

ISIN 

GB00B784NS11

UCITS 

Yes

This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment

Before investing please read:

Key Investor Information Document (KIID)

Growth of 10k

Asset allocation

Top 10 holdings

Holdings 31/03/2025% of assets
Vertex Pharmaceuticals Inc9.25
Amgen Inc7.89
AstraZeneca PLC ADR6.97
Regeneron Pharmaceuticals Inc6.52
Gilead Sciences Inc5.35
Alnylam Pharmaceuticals Inc4.38
argenx SE ADR3.89
Insmed Inc3.56
Neurocrine Biosciences Inc2.94
Biomarin Pharmaceutical Inc2.78

Performance 30/04/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund+ 1.50
Category-
More...

Investment objective

The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Morningstar ratingTM

Morningstar sustainability ratingTM

Morningstar Medalist RatingTM

  Morningstar analyst document

  Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.